ACET

Adicet Bio Stock Price

14.93
0.39 (2.68%)
Upgrade to Real-Time
Regular Market
14.93
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Adicet Bio Inc ACET NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.39 2.68% 14.93 14:40:18
Open Price Low Price High Price Close Price Prev Close
14.76 14.0667 14.9999 14.54
Bid Price Ask Price Spread News
14.72 14.95 0.23 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
298 23,716 $ 14.59 $ 345,903 75,939 9.71 - 21.40
Last Trade Time Type Quantity Stock Price Currency
14:40:18 68 $ 14.94 USD

Adicet Bio Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 292.48M 19.59M 27.84M $ 12.49M $ - -2.47 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Adicet Bio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACET Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week13.1415.18512.6814.3287,6101.7913.62%
1 Month14.4415.18512.6813.9248,7450.493.39%
3 Months10.8515.389.7113.4359,1964.0837.6%
6 Months14.9821.409.7112.7298,332-0.05-0.33%
1 Year14.9821.409.7112.7298,332-0.05-0.33%
3 Years11.2021.400.13061.88911,1183.7333.3%
5 Years23.4925.980.13065.65538,412-8.56-36.44%

Adicet Bio Description

Adicet Bio Inc is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.


Your Recent History
NASDAQ
ACET
Adicet Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.